Search Our Site

News tagged with:

"treatment"

A wearable system to monitor the stomach’s activity throughout the day

A team of researchers has developed a wearable, non-invasive system to monitor electrical activity in the stomach over 24 hours — essentially an electrocardiogram but for the gastro-intestinal (GI) tract. Applications include monitoring GI activity for patients outside of a clinical setting, which cuts down costs. Monitoring for longer periods of time also increases the... Read More »

Read More →

A team of researchers has developed a wearable, non-invasive system to monitor electrical activity in the stomach over 24 hours — essentially an electrocardiogram but for the gastro-intestinal (GI) tract. Applications include monitoring GI activity for patients outside of a clinical setting, which cuts down costs. Monitoring for longer periods of time also increases the… Read More »

[...]

Read More

Unnecessary Medical Care Is More Common Than You Think

A study in Washington state found that in a single year more than 600,000 patients underwent treatment they didn’t need, at an estimated cost of $282 million. “Do no harm” should include the cost of care, too, the report author says. It’s one of the intractable financial boondoggles of the U.S. health care system: Lots... Read More »

Read More →

A study in Washington state found that in a single year more than 600,000 patients underwent treatment they didn’t need, at an estimated cost of $282 million. “Do no harm” should include the cost of care, too, the report author says. It’s one of the intractable financial boondoggles of the U.S. health care system: Lots… Read More »

[...]

Read More

Screening, Treatment Cuts Breast Cancer Deaths in Half

Breakthroughs in breast cancer screening and treatment have slashed the percentage of women dying from the disease, a new analysis reveals. “Advances in screening and treatment are saving lives,” said lead researcher Sylvia Plevritis, a professor of radiology and biomedical data science at the Stanford University School of Medicine. “Here’s an example that all this... Read More »

Read More →

Breakthroughs in breast cancer screening and treatment have slashed the percentage of women dying from the disease, a new analysis reveals. “Advances in screening and treatment are saving lives,” said lead researcher Sylvia Plevritis, a professor of radiology and biomedical data science at the Stanford University School of Medicine. “Here’s an example that all this… Read More »

[...]

Read More

FDA approves first biosimilar for the treatment of certain breast and stomach cancers

The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or... Read More »

Read More →

The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or… Read More »

[...]

Read More

Gene Therapy May Fight Brain Cancer’s Return

A new form of gene therapy shows promise in battling recurrent brain cancer. The phase 1 clinical trial included 56 patients with recurrent high-grade glioma brain cancer. Three years after the gene therapy treatment, more than a quarter of the patients were still alive. Median survival for patients was 14.4 months, compared with eight months... Read More »

Read More →

A new form of gene therapy shows promise in battling recurrent brain cancer. The phase 1 clinical trial included 56 patients with recurrent high-grade glioma brain cancer. Three years after the gene therapy treatment, more than a quarter of the patients were still alive. Median survival for patients was 14.4 months, compared with eight months… Read More »

[...]

Read More

Read the Fine Print on the $475,000 Price of a Cancer Breakthrough

Novartis could have priced Kymriah much higher, and it’s being unusually flexible. Kicking it off, Gilead Sciences Inc. bought Kite Pharma Inc., a pioneer in “CAR-T” cell therapy, which uses a patient’s immune cells to potentially eradicate blood cancers with just one treatment. And on Wednesday, Novartis AG’s entry in this field, Kymriah, became the first such... Read More »

Read More →

Novartis could have priced Kymriah much higher, and it’s being unusually flexible. Kicking it off, Gilead Sciences Inc. bought Kite Pharma Inc., a pioneer in “CAR-T” cell therapy, which uses a patient’s immune cells to potentially eradicate blood cancers with just one treatment. And on Wednesday, Novartis AG’s entry in this field, Kymriah, became the first such… Read More »

[...]

Read More

Meds by Monthly Injection Might Revolutionize HIV Care

Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay New research suggests that injectable, long-acting antiretroviral therapy for HIV is as safe and effective as oral medications. The injection — given every four or... Read More »

Read More →

Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay New research suggests that injectable, long-acting antiretroviral therapy for HIV is as safe and effective as oral medications. The injection — given every four or… Read More »

[...]

Read More

Tumor Test Helps Identify Which Breast Cancers Don’t Require Extra Treatment

For years, doctors have focused on detecting breast cancer at the earliest possible moment after a tumor develops so treatment can start right away. But more and more studies are showing many small, early tumors don’t present a danger. So, when is it safe to remove a tumor but skip additional treatments like tamoxifen, chemotherapy... Read More »

Read More →

For years, doctors have focused on detecting breast cancer at the earliest possible moment after a tumor develops so treatment can start right away. But more and more studies are showing many small, early tumors don’t present a danger. So, when is it safe to remove a tumor but skip additional treatments like tamoxifen, chemotherapy… Read More »

[...]

Read More

CAR T-cell Therapy May Thwart Multiple Myeloma

Genetically tuning a person’s own immune cells to target cancer appears to provide long-lasting protection against a blood cancer called multiple myeloma, an early trial from China shows. The treatment, called CAR T-cell therapy, caused 33 out of 35 patients with recurring multiple myeloma to either enter full remission or experience a significant reduction in... Read More »

Read More →

Genetically tuning a person’s own immune cells to target cancer appears to provide long-lasting protection against a blood cancer called multiple myeloma, an early trial from China shows. The treatment, called CAR T-cell therapy, caused 33 out of 35 patients with recurring multiple myeloma to either enter full remission or experience a significant reduction in… Read More »

[...]

Read More

A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here’s What It Teaches Us

Derek Laurie was working as a tow truck driver, living in a suburb outside Rochester, New York, and supporting two small children. It was tough work. He climbed under wrecked vehicles, or swam into ponds. So he thought the pains were pulled muscles. Maybe he was drinking too much beer. He stayed in denial until... Read More »

Read More →

Derek Laurie was working as a tow truck driver, living in a suburb outside Rochester, New York, and supporting two small children. It was tough work. He climbed under wrecked vehicles, or swam into ponds. So he thought the pains were pulled muscles. Maybe he was drinking too much beer. He stayed in denial until… Read More »

[...]

Read More

Page 1 of 2

Categories
Archives